補足図S2 内分泌療法はSMAC模倣物と相乗効果を示し、ホルモン受容体陽性乳がんにおける抗原提示と腫瘍退縮を促進する

Hermida‐Pradoら（Mon,）がこの問題を研究した。

www.synapsesocial.com/papers/68e586b5b6db643587523180 — DOI: https://doi.org/10.1158/0008-5472.27028627

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Fig. S2 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
2. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
3. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
4. Supplementary Fig. S3 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
5. Supplementary Fig. S3 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024